Hexoprenaline
From Wikipedia, the free encyclopedia
 |
|
|---|---|
| Systematic (IUPAC) name | |
| (±)-4,4'-{hexane-1,6-diylbis[imino(1-hydroxyethane-2,1-diyl)]}dibenzene-1,2-diol | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 3215-70-1  |
| ATC code | R03AC06 R03CC05 |
| PubChem | CID 3609 |
| UNII | G9L6B3W684 |
| Synonyms | 4-[2-[6-([2-(3,4-dihydroxyphenyl)-2-hydroxyethyl]amino)hexylamino]-1-hydroxyethyl]benzene-1,2-diol |
| Chemical data | |
| Formula | C22H32N2O6 |
| Mol. mass | 420.499 g/mol |
| SMILES | eMolecules & PubChem |
 (what is this?) (verify) |
Hexoprenaline (INN) is a β2-adrenergic receptor agonist used in the treatment of asthma.[1]
Hexoprenaline is also used as a tocolytic agent (i.e., It can suppress labor). Contraindications to its use as a tocolytic agent are cardiovascular disease, surgical shock, tachycardia, diabetes mellitus.
[edit] References
- ^ Pinder, RM; Brogden, RN; Speight, TM; Avery, GS (1977). "Hexoprenaline: a review of its pharmacological properties and therapeutic efficacy with particular reference to asthma". Drugs 14 (1): 1–28. PMID 195789.
|
 |
This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it. |
